Identification of patients receiving amyloid‐targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADS

Abstract INTRODUCTION As amyloid‐targeting therapies (ATTs) enter clinical care, observational cohorts must accurately ascertain ATT exposure. We developed an approach to flag mis/undocumented ATT in the Longitudinal Early‐Onset Alzheimer's Disease Study using longitudinal amyloid positron emission...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Renaud La Joie, Ganna Blazhenets, Piyush Maiti, Konstantinos Chiotis, Ani Eloyan, Kala Kirby, Dustin Hammers, Robert A. Koeppe, Sarah F. Ackley, Justin Robison, David N. Soleimani‐Meigooni, Maria C. Carrillo, Bradford C. Dickerson, Liana G. Apostolova, Gil D. Rabinovici, for the LEADS consortium
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Wiley 2026-04-01
Цуврал:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Нөхцлүүд:	Centiloids early‐onset Alzheimer's disease measurement error treatment‐related amyloid clearance
Онлайн хандалт:	https://doi.org/10.1002/dad2.70408
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!